Rein Therapeutics Inc. (RNTX) ownership: Top institutional holder: Voss Capital, LP ($5.70M). Insider activity: Net Seller (0 buys, 6 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Voss Capital, LP | 4388362.00 | $5.70M | 2026-03-31 |
| BIOS Capital Management, LP | 1982375.00 | $2.58M | 2026-03-31 |
| VANGUARD GROUP INC | 1165807.00 | $1.35M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 998521.00 | $1.30M | 2026-03-31 |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 511610.00 | $665093.00 | 2026-03-31 |
| Cable Car Capital, LP | 420000.00 | $546000.00 | 2026-03-31 |
| Prosight Management, LP | 411600.00 | $535080.00 | 2026-03-31 |
| Sigma Planning Corp | 348677.00 | $453280.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-26 | |
| Sell | null | 2026-05-22 | |
| Sell | null | 2026-05-21 | |
| Sell | null | 2026-05-08 | |
| Sell | null | 2026-04-30 |
Back to RNTX overview · RNTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.